HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dawn M Carlson Selected Research

fenofibric acid

6/2014Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
8/2013A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
8/2012Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
2/2011Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
12/2010Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.
10/2010Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
1/2010Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dawn M Carlson Research Topics

Disease

6Dyslipidemias (Dyslipidemia)
06/2014 - 10/2010
5Neoplasms (Cancer)
11/2015 - 09/2005
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2015 - 08/2011
4Hypertension (High Blood Pressure)
11/2013 - 08/2011
3Hepatocellular Carcinoma (Hepatoma)
01/2015 - 01/2013
3Coronary Disease (Coronary Heart Disease)
06/2014 - 10/2010
3Diarrhea
11/2013 - 08/2011
2Thrombocytopenia (Thrombopenia)
09/2014 - 07/2014
2Proteinuria
11/2013 - 08/2011
2Fatigue
01/2013 - 08/2011
1Pain (Aches)
08/2016
1Hidradenitis Suppurativa
08/2016
1Hypothyroidism
09/2014
1Colorectal Neoplasms (Colorectal Cancer)
09/2014
1Neutropenia
07/2014
1Leukopenia
07/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2014
1Asthenia
11/2013
1Chronic Renal Insufficiency
08/2013
1Hepatitis B
01/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2012
1Cardiovascular Diseases (Cardiovascular Disease)
08/2012
1Breast Neoplasms (Breast Cancer)
06/2012
1Lung Neoplasms (Lung Cancer)
06/2012
1Sarcoma (Soft Tissue Sarcoma)
06/2012
1Thymus Neoplasms (Thymus Neoplasm)
06/2012
1Renal Cell Carcinoma (Grawitz Tumor)
12/2011
1Nausea
08/2011
1Type 2 Diabetes Mellitus (MODY)
02/2011
1Rhabdomyolysis
01/2010
1Hypercholesterolemia
01/2010
1Hypertriglyceridemia
01/2010
1Myotoxicity
01/2010

Drug/Important Bio-Agent (IBA)

12linifanibIBA
11/2015 - 08/2011
7fenofibric acidFDA Link
06/2014 - 01/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 08/2011
5HDL CholesterolIBA
06/2014 - 10/2010
5Triglycerides (Triacylglycerol)IBA
06/2014 - 10/2010
5LipidsIBA
08/2013 - 01/2010
5Rosuvastatin Calcium (Crestor)FDA Link
08/2013 - 01/2010
4Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2015 - 08/2011
4LDL CholesterolIBA
06/2014 - 10/2010
4oxidized low density lipoproteinIBA
08/2012 - 10/2010
3Carboplatin (JM8)FDA LinkGeneric
11/2015 - 07/2014
3Paclitaxel (Taxol)FDA LinkGeneric
11/2015 - 07/2014
2Atorvastatin (Lipitor)FDA Link
06/2014 - 08/2012
2Fibric Acids (Fibrates)IBA
06/2014 - 01/2010
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2014 - 01/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2016
1Adalimumab (Humira)FDA Link
08/2016
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2015
1Biomarkers (Surrogate Marker)IBA
11/2015
1Platelet-Derived Growth FactorIBA
02/2015
1Sorafenib (BAY 43-9006)FDA Link
01/2015
1Bevacizumab (Avastin)FDA Link
09/2014
1Phosphotransferases (Kinase)IBA
07/2014
1Fenofibrate (CiL)FDA LinkGeneric
06/2014
1Choline (Choline Chloride)IBA
06/2014
1Cytarabine (Cytosar-U)FDA LinkGeneric
08/2012
1Sunitinib (Sutent)FDA Link
12/2011
1Apolipoproteins B (ApoB)IBA
02/2011
1ApolipoproteinsIBA
02/2011
1Simvastatin (Zocor)FDA LinkGeneric
01/2010

Therapy/Procedure

9Therapeutics
01/2015 - 09/2005
1Aftercare (After-Treatment)
02/2011